64B16-26.1001: Examination and Application Fees
PURPOSE AND EFFECT: The Board proposes the rule amendment to remove references to the application fee for continuing education course approval.
SUMMARY: References to the application fee for continuing education course approval will be removed from the rule.
SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS: No Statement of Estimated Regulatory Cost was prepared.
Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
SPECIFIC AUTHORITY: 465.005, 465.009 FS.
LAW IMPLEMENTED: 456.025(7), 465.007, 465.0075, 465.009 FS.
IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN FAW.
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Rebecca R. Poston, Executive Director, Board of Pharmacy/MQA, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3253
THE FULL TEXT OF THE PROPOSED RULE IS:
64B16-26.1001 Examination and Application Fees.
(1) The non-refundable examination fee for licensure by examination shall be $100, payable to the Board. Examination fees for the National Practice Examination and jurisprudence examination are payable to the examination vendor.
(2) The non-refundable application fee licensure by endorsement shall be $100, payable to the Board.
(3) The non-refundable application fee for a continuing education provider seeking approved provider status shall be $150, payable to the Board.
(4) The non-refundable application fee for a continuing education course approval shall be $50 for each course submitted for approval, payable to the Board.
Specific Authority 465.005, 465.009 FS. Law Implemented 456.025(7), 465.007, 465.0075, 465.009 FS. HistoryNew 1-11-05, Amended_________.
